Health and Healthcare

All Health and Healthcare Articles

Newest first · Page 338

Array Biopharma (ARRY) Gets Lucky

Small biopharma stocks sometimes have that one big day, the day that there investors wait for. Array Biopharma (NASDAQ:ARRY) moved higher by 30% early in the day to $3.11. The little firm entered into an…

Douglas A. McIntyre · 17 years ago

52-Week High Club (MMM, COO)

3M Company (NYSE: MMM) rose nearly 4% to a yearly high of $79.93 after the Post-It Notes maker was upgraded to “buy” by Jeffrey Sprague of Citigroup. The Cooper Companies Inc (NYSE: COO) surged…

Douglas A. McIntyre · 17 years ago

Top Day Trader Alerts (AAPL, SQNM, NLST, DNDN, TXN, AVNR)

These are this morning’s key day trader and active trader alert stocks.  We have given more details and analysis on each stock and story with a link over to VSInvestor.com: We have given new…

Douglas A. McIntyre · 17 years ago

Amgen: Stock Buyback vs. Debt Repayment (AMGN)

Do you have to worry when biotech giants decide to spend their hard-earned cash repurchasing their own stock rather than using the cash to go purchase new pipelines?  That is what we’d like to…

Douglas A. McIntyre · 17 years ago

Stem Cell Stocks Take Off (ASTM, GERN, OPXA, STEM)

Tickerspy’s Stem Cell Stock Index (*RSXTM) took off today, rising nearly 13%.  The movement followed a release from the National Institutes of Health  (NIH) announcing that 13 embryonic stem cell lines were approved for…

Douglas A. McIntyre · 17 years ago

Reynolds: Smoking to Smoking Cessation (RAI, GSK)

Reynolds American Inc. (NYSE: RAI) has an interesting approach in M&A today.  The deal is a tiny merger valued at $44 million when you consider that Reynolds has almost a $15 billion market cap,…

Douglas A. McIntyre · 17 years ago

Human Genome Sciences Raising Cash (HGSI)

Human Genome Sciences, Inc. (NASDAQ: HGSI) is rasing cash.  The company announced that it is selling up to 12.5 million shares of common stock. The company earmarked funds for general corporate purposes, which includes…

Douglas A. McIntyre · 17 years ago

The Great Merck Buyback.. Dividend Too (MRK)

Merck & Co., Inc. (NYSE: MRK) barely has its Schering-Plough deal behind it.  And today came the announcement of its dividend rate, but more importantly came word of a large share repurchase program.  The…

Douglas A. McIntyre · 17 years ago

52-Week High Club (DDS, DBRN, SJM, MRK)

Dillard’s Inc. (NYSE: DDS) rose as high as over 10% to a yearly high of $15.79 after the department-store chain was upgraded by Deutsche Bank AG.   Dress Barn Inc. (NASDAQ: DBRN) rose as…

Douglas A. McIntyre · 17 years ago

Major Rumor: CBO Says Senate Healthcare To Cost $849 Billion

At this point it is simply a rumor, but The Wall Street Journal reports that : “Senate Democrats’ health-care legislation has been estimated to cost $849 billion and to reduce the federal budget deficit by…

Douglas A. McIntyre · 17 years ago

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once again why much of the criticism is justified. The FDA today said that two…

Douglas A. McIntyre · 17 years ago

Bristol-Myers Cleans Up on Mead Johnson (BMY, MJN)

Bristol-Myers Squibb Company (NYSE: BMY) is going to completely separate itself from its holdings in Mead Johnson Nutrition Company (NYSE: MJN).  The company expects that the split-off will be a tax-advantaged way to divest…

Douglas A. McIntyre · 17 years ago

52-Week High Club (NCST, SMD)

NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST) rose over 70% to a yearly high of $1.70.  Its rise was driven by the news that Smith & Nephew Plc (NYSE: SNN) has agreed to buy nearly all…

Douglas A. McIntyre · 17 years ago

52-Week High Club

CareFusion Corp. (NYSE: CFN)  rose over 6% to a yearly hight of $24.34  after reporting first quarter earnings of 39 cents per share, beating analyst estimates.  The company also increased its earnings forecast for…

Douglas A. McIntyre · 17 years ago